These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 460544

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Differential modification by opioid agents of acutely enhanced noradrenaline release in discrete brain regions.
    Kohno Y, Tanaka M, Hoaki Y, Ida Y, Nagasaki N.
    Eur J Pharmacol; 1983 Sep 02; 92(3-4):265-8. PubMed ID: 6313396
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Noradrenergic and behavioural effects of naloxone injected in the locus coeruleus of morphine-dependent rats and their control by clonidine.
    Esposito E, Kruszewska A, Ossowska G, Samanin R.
    Psychopharmacology (Berl); 1987 Sep 02; 93(3):393-6. PubMed ID: 3124170
    [Abstract] [Full Text] [Related]

  • 27. Amphetamine withdrawal: effects on brain levels of MHPG-SO4 in the rat.
    Cassens G, Kuruc A, Orsulak PJ, Schildkraut JJ.
    Commun Psychopharmacol; 1979 Sep 02; 3(4):217-23. PubMed ID: 575083
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Further characterization of brain 3,4-dihydroxyphenylethyleneglycol (DHPG) formation: dependence on noradrenergic activity and site of formation.
    Li PP, Warsh JJ, Godse DD.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan 02; 332(1):26-33. PubMed ID: 3951564
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Formation and clearance of norepinephrine glycol metabolites in mouse brain.
    Li PP, Warsh JJ, Godse DD.
    J Neurochem; 1984 Nov 02; 43(5):1425-33. PubMed ID: 6491661
    [Abstract] [Full Text] [Related]

  • 34. Effects of the d- and l-isomers of amphetamine on the levels of 3-methoxy-4-hydroxyphenylglycol sulfate in whole rat brain and rat brain regions.
    Roffman M, Cassens G, Schildkraut JJ.
    Biochem Pharmacol; 1978 Nov 02; 27(13):1774-7. PubMed ID: 708459
    [No Abstract] [Full Text] [Related]

  • 35. Interaction of antidepressants with clonidine on rat brain total 3-methoxy-4-hydroxyphenylglycol.
    Tang SW, Helmeste DM, Stancer HC.
    Can J Physiol Pharmacol; 1979 Apr 02; 57(4):435-7. PubMed ID: 455145
    [Abstract] [Full Text] [Related]

  • 36. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
    Karoum F, Korpi ER, Linnoila M, Chuang LW, Wyatt RJ.
    Eur J Pharmacol; 1984 Apr 20; 100(2):137-44. PubMed ID: 6234178
    [Abstract] [Full Text] [Related]

  • 37. Measurement of 3-methoxy-4-hydroxyphenylglycol (MHPG) in mouse brain by h.p.l.c. with electrochemical detection, as an index of noradrenaline utilisation and presynaptic alpha 2-adrenoceptor function.
    Heal DJ, Prow MR, Buckett WR.
    Br J Pharmacol; 1989 Mar 20; 96(3):547-56. PubMed ID: 2541844
    [Abstract] [Full Text] [Related]

  • 38. [Participation of spinal norepinephrine in morphine analgesia in rats].
    Xie CW, Du XL, Tang J, Han JS.
    Sheng Li Xue Bao; 1985 Jun 20; 37(3):258-64. PubMed ID: 2871628
    [No Abstract] [Full Text] [Related]

  • 39. Clonidine reversal of increased norepinephrine metabolite levels during morphine withdrawal.
    Crawley JN, Laverty R, Roth RH.
    Eur J Pharmacol; 1979 Aug 01; 57(2-3):247-50. PubMed ID: 573692
    [Abstract] [Full Text] [Related]

  • 40. Role of serotonin in morphine effects.
    Way EL.
    Fed Proc; 1972 Aug 01; 31(1):113-20. PubMed ID: 4333247
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.